Home > Insider Trading > Filing (0001181431-13-059560)

Filing Details

Accession Number:: 0001181431-13-059560
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-11-18 21:23:21
Reporting Period:: 2013-11-14

Filing Date:: 2013-11-18
Accepted Time:: 2013-11-18 21:23:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1463729	Receptos Inc.	RCPT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575843	Amir Nashat	10835 Road To The Cure Suite 205 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-11-14	145,582	$25.00	1,040,508	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-11-14	8,507	$25.00	1,032,001	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-11-15	14,245	$24.54	1,017,756	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2013-11-15	981	$24.54	1,016,775	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4.
The reportable securities are owned directly by Polaris Venture Partners VI, L.P. ("PVP VI"). Polaris Venture Management Co. VI, LLC ("PVM VI") is the general partner of PVP VI. PVM IV disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM VI is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
The reportable securities are owned directly by Polaris Venture Partners Founders' Fund VI, L.P. ("PVPF VI"). PVM VI is the general partner of PVPF VI. PVM IV disclaims beneficial ownership of these securities and this report shall not be deemed an admission that PVM VI is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4) to this Form 4.